Appointment of first Chief Medical Officer, Chief Information Officer, Chief People officer Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of nanopore based molecular sensing, today announces the appointments of Davide Manissero MD as Chief Medical Officer, Andrew Watson as Chief Information Officer and the joining of Tina St Leger as Chief […]
New Biacore 8S and Biacore 8S+ systems combine rapid screening and high-quality molecular characterization in a single system Biacore Insight Software v7.0 adds Sensorgram comparison for objective similarity scoring Cytiva, a Danaher company and a leader in the life sciences industry, is introducing the next generation of its Biacore 8 series SPR systems, enabling scientists […]
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases Goal to advance how disease mechanisms, therapeutic targets and biomarkers are identified Graph-based AI approach designed to help researchers explore mechanisms, therapeutic targets and biomarkers with greater speed, context and confidence Initial pilot programs available to select […]
Endeavor® Live Cell enables rapid kinetic imaging across large scale screening campaigns, generating the cellular data needed to support Lab-in-the-Loop drug discovery workflows. PORTLAND, Ore. — Araceli Biosciences today announced the launch of Endeavor® Live Cell, extending the company’s ultra-high-throughput imaging platform into dynamic biology at screening scale. As AI-driven drug discovery evolves toward Lab-in-the-Loop workflows, researchers need more […]
Nanopore sequencing combined with machine learning and dedicated workflows simplifies complex QC testing by measuring multiple critical quality attributes in one test Technology designed to support scalable, high‑quality mRNA manufacturing, accelerates the path to market for mRNA products and enables improved quality and control strategies Novel approach enables streamlined, multi-attribute QC release approach that supports […]
DURHAM, N.C. and IPSWICH, Mass. — EpiCypher® and New England Biolabs® (NEB®) today announced an expanded strategic partnership to co-develop next-generation tools for epigenomics research. Building on a successful track record of collaboration, the partnership will accelerate the creation of innovative technologies that advance understanding of gene regulation, chromatin biology, and disease mechanisms. The partnership combines EpiCypher’s strengths […]
Stockholm, Sweden — Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced an agreement with the National Genomics Infrastructure (NGI), one of the largest technical platforms at SciLifeLab. NGI Stockholm has become the first official core laboratory and service provider globally to offer Epigenica’s EpiFinder™ platform. This milestone represents a significant step in […]
MONMOUTH JUNCTION, N.J. — TheWell Bioscience, a biotechnology company pioneering advanced 3D cell culture technologies, today announced the launch of its RocketCell™ Organoid Xeno-Free Essential-Core Medium, a chemically defined, universal foundation medium designed to streamline organoid culture workflows while enhancing reproducibility, scalability, and cost efficiency. As organoid models continue to expand across disease modeling, drug discovery, and precision […]
The only assay-ready immunocompetent 3D brain organoid model incorporating microglia for studies of neuroinflammatory mechanisms and drug efficacy Expands the ability to model human pathogenesis and functional recovery for neurodegenerative diseases NEW ORLEANS — 28bio today announced CNS-3D Inflammatory Organoids, designed to evaluate efficacy of anti-inflammatory drugs by quantifying their ability to reduce inflammatory injury, preserve tissue health, […]
OmicsHQ brings together comprehensive, expertly curated, standardized multi-omics datasets from across the scientific ecosystem, complete with pre-processed datasets ready to accelerate research, drug-discovery, and AI-driven innovation. SAN DIEGO — Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQTM, a unified catalog of expertly curated, standardized multi-omics datasets designed for immediate […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
